Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
09/2000
09/21/2000WO2000055147A1 Fused 1,4-thiazine-2-carbonitrile derivatives, their preparation and use
09/21/2000WO2000055144A1 Amine derivatives as protease inhibitors
09/21/2000WO2000055139A2 Heterocyclic urea and related compounds useful as anti-inflammatory agents
09/21/2000WO2000055137A1 Compounds and methods for modulation of estrogen receptors
09/21/2000WO2000055132A1 New salt of (2r,3r,4r)-3,4-dihydroxy-2-hydroxymethylpyrrolidine
09/21/2000WO2000055131A1 New salt of (2r,3r,4r)-3,4-dihydroxy-2-hydroxymethylpyrrolidine
09/21/2000WO2000055127A1 Gamma-ketoacid dipeptides as inhibitors of caspase-3
09/21/2000WO2000055126A2 N-cyanomethylamides as protease inhibitors
09/21/2000WO2000055125A2 N-cyanomethyl amides as protease inhibitors
09/21/2000WO2000055118A1 Nuclear receptor arylating compounds
09/21/2000WO2000055114A1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof
09/21/2000WO2000054838A1 Calcium-containing composition
09/21/2000WO2000054813A2 Use of recombinant gene delivery vectors for treating or preventing diseases of the eye
09/21/2000WO2000054799A2 Medicament for treating diabetes
09/21/2000WO2000054794A1 Wafer delivery system
09/21/2000WO2000054765A1 Method of treating eating disorders
09/21/2000WO2000054764A2 A method of treating bulimia nervosa and related eating disorders by administration of atypical antipsychotic medications
09/21/2000WO2000054763A2 Pharmaceutical compositions comprising polymorphic forms of dehydroepiandrosterone
09/21/2000WO2000054759A2 Lxr modulators
09/21/2000WO2000054729A2 Heterocyclic aromatic compounds useful as growth hormone secretagogues
09/21/2000WO2000054610A1 Food complement and method for cosmetic treatment based on a grape extract rich in polyphenols
09/21/2000WO2000040716A3 Soluble receptor br43x2 and methods of using them for therapy
09/21/2000WO2000040225A3 Inhibition of tnf activity
09/21/2000WO2000039077A3 Thyroid receptor ligands
09/21/2000WO2000038785A3 Methods for treating certain diseases using naaladase inhibitors
09/21/2000WO2000029846A9 COMPOSITIONS AND METHODS RELATING TO THE PEROXISOMAL PROLIFERATOR ACTIVATED RECEPTOR-α MEDIATED PATHWAY
09/21/2000WO2000026227A9 Ldl related protein and uses thereof
09/21/2000WO2000010551A3 Methods of using and compositions comprising dopamine reuptake inhibitors
09/21/2000DE19910682A1 Fibrate based preparation for treating hyperlipoproteinemia additionally contains vitamin or related compound, e.g. cobalamin or folic acid, to prevent the side effect of hyperhomocysteinemia
09/21/2000DE19901502C1 Anticellulitiszusammensetzung und ihre Verwendung Anticellulitiszusammensetzung and their use
09/21/2000DE10012095A1 Treatment of diabetes mellitus using mixture of enzymes having lipolytic, proteolytic and amylolytic activity, e.g. pancreatin, regulates glycemia and also reduces post-complications
09/21/2000CA2368148A1 Novel compounds and compositions as protease inhibitors
09/21/2000CA2368122A1 Novel compounds and compositions as protease inhibitors
09/21/2000CA2367895A1 Compounds and methods for modulation of estrogen receptors
09/21/2000CA2367862A1 Gamma-ketoacid dipeptides as inhibitors of caspase-3
09/21/2000CA2367595A1 Lxr modulators
09/21/2000CA2367461A1 Heterocyclic aromatic compounds useful as growth hormone secretagogues
09/21/2000CA2367375A1 Use of recombinant gene delivery vectors for treating or preventing diseases of the eye
09/21/2000CA2367354A1 6-substituted biaryl purine derivatives as potent cyclin/cdk inhibitors and antiproliferative agents
09/21/2000CA2367352A1 Amine derivatives as protease inhibitors
09/21/2000CA2367340A1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof
09/21/2000CA2366838A1 A method of treating bulimia nervosa and related eating disorders by administration of atypical antipsychotic medications
09/21/2000CA2365655A1 Retrovirus producting cells utilizing a high multiplicity of transduction
09/21/2000CA2364739A1 Regulators of intracellular phosphorylation
09/21/2000CA2364046A1 Food complement and method for cosmetic treatment based on a grape extract rich in polyphenols
09/21/2000CA2363022A1 49 human secreted proteins
09/21/2000CA2361939A1 Modified amino acid amides, pharmaceutical compositions containing these compounds and processes for preparing them
09/21/2000CA2332767A1 Dhea composition and method
09/20/2000EP1036783A1 Crystalline hydrated dihydroxy open-acid simvastatin calcium salt
09/20/2000EP1036565A1 Preventives/remedies for diabetes
09/20/2000EP1036564A1 Thyromimetic antiobesity agents
09/20/2000EP1036563A1 Delayed-release oral formulation of dihydroxy open acid simvastatin and salts and esters thereof
09/20/2000EP1036191A2 Method for identifying ihbitors of g-protein coupled receptor hibef51
09/20/2000EP1036175A1 Human brain derived kcnq2 potassium channel
09/20/2000EP1036075A1 Substituted thiazolidinedione and oxazolidinedione having antidiabetic, hypolipidemia and antihypertensive properties
09/20/2000EP1036064A1 Selective beta 3-adrenergic agonists
09/20/2000EP1035856A1 Isolated dna encoding human h3 histamine receptor
09/20/2000EP1035851A2 Method for combating obesity
09/20/2000EP1035824A1 A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs
09/20/2000EP0766735B1 Class bi and ci scavenger receptors
09/20/2000EP0734376B1 Vitamin d amine and amide derivatives
09/20/2000EP0672057B1 Analogs of pth
09/20/2000CN1266695A Preparation for treating diabetes
09/20/2000CN1266686A Medicinal composition for treating diabetes
09/20/2000CN1056618C Acylated insulin and pharmaceutical composition contg. same
09/20/2000CN1056611C Pyrazolo and pyrrolopyridines, their use and intermidiates for preparing same
09/20/2000CN1056608C Pseudodipeptide product having imidazole group and applications
09/20/2000CN1056607C Tricyclic pyrazole derivs.
09/20/2000CN1056520C Anti-senility hypolpemic Chinese medicine liquor
09/19/2000US6121461 Form III crystalline [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl )-3-phenyl-4-[(phenylamino) carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1)
09/19/2000US6121416 Peptide which prevents the binding of somatomedins and their binding proteins; for the treatment of hyperglycemic, obesity, nervous system, cardiovascular, kidney, immunological and metabolic disorders
09/19/2000US6121330 Cardiovascular disorders; anticholesterol agents; antilipemic agents
09/19/2000US6121325 Naphthyl compounds promote release of growth hormone
09/19/2000US6121316 2-cyano-3,5-dihydroxyhex-2-enecarboxamide derivatives
09/19/2000US6121312 Cyclic ether vitamin D3 compounds and uses thereof
09/19/2000US6121304 Pentafluorobenzenesulfonamides and analogs
09/19/2000US6121295 Treating diabetic complications by administering an insulin sensitivity enhancer such as pioglitazone in combination with a statin compound such as pravastatin
09/19/2000US6121294 Reducing the amount of therapeutic agents administered to a diabetic patient by administering an insulin sensitivity enhancer in combination with an alpha-glucosidase inhibitor as said therapeutic agents; side effect reduction
09/19/2000US6121293 Benzothiophene compounds, compositions, and methods
09/19/2000US6121288 Visceral fat lowering agent
09/19/2000US6121283 N-substituted-6-(2-(4-trifluoromethylphenyl)phenylcarbonyl-amino) -1,2,3,4-tetrahydroisoquinolines; treating disorders including obesity, hyperlipidemia, and diabetes; microsomal triglyceride transfer protein (mtp); apolipoprotein b (apo-b)
09/19/2000US6121282 3-(carboxy, amido, cyano, or hydroxyaminocarbonyl)-6 or 7-substituted-1,2,3,4-tetrahydroisoquinoline compounds
09/19/2000US6121260 Appetite stimulation with dosage of neuropeptide y (npy) receptor agonist
09/19/2000US6121253 Prostaglandin conjugates for treating or preventing bone disease
09/19/2000CA2184914C Isoxazoline compounds as 5-lipoxygenase inhibitors
09/19/2000CA2107484C New arylalkyl(thio)amides, their preparation process and pharmaceutical compositions containing them
09/19/2000CA2071538C Hpth (1-37) fragment, its production, drug containing it and its use
09/19/2000CA2029420C Pharmaceutical compositions and methods for inhibition of maillard's reaction
09/14/2000WO2000053635A1 Anti-gpr-9-6 and anti-teck antibodies and methods of identifying modulators of gpr-9-6 and teck functions
09/14/2000WO2000053608A1 Pyridopyranoazepine derivatives, preparation and therapeutic use
09/14/2000WO2000053606A1 Pyridoxal analogues for vitamin b-6 disorders
09/14/2000WO2000053605A1 Tyrosine kinase inhibitors
09/14/2000WO2000053583A1 Inhibitors of protein tyrosine phosphatase
09/14/2000WO2000053566A1 Crystalline hydrated dihydroxy open-acid simvastatin calcium salt
09/14/2000WO2000053563A1 Novel ligands of nuclear receptors ppar's
09/14/2000WO2000053233A1 Use of protein conformation for the protection and release of chemical compounds
09/14/2000WO2000053173A1 Dihydroxy open-acid and salts of hmg-co-a reductase inhibitors
09/14/2000WO2000053171A1 Use of metformin in the preparation of pharmaceutical compositions capable of inhibiting the enzyme dipeptidyl peptidase iv
09/14/2000WO2000037469A3 Process for preparing n6-substituted deaza-adenosine derivatives
09/14/2000WO2000037422A3 Ion channel modulating agents
1 ... 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 ... 1298